Residents/Fellows: Page 60

Final 510(k) approvals for November 2000

Issued December 5, 2000
Each month the U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) releases a final list of devices approved for marketing in the U.S. during the previous month. The following is a list of 510(k) final decisions rendered for November 2000.

December 4, 2000

Interstitial lung diseases: Imaging evaluation

By Michael B. Gotway

November 16, 2000

Missed breast cancer: Avoiding this pitfall

By Ellen Shaw de Parides

Perception and interpretation problems account for many missed breast cancers. Radiologists must pay careful attention to film review; searching for developing densities, focal asymmetries, and masses; and perform complete diagnostic evaluation of potential lesions detected.

November 16, 2000

Perception factors

Part II: Missed breast cancer: Avoiding this pitfall

November 16, 2000

Interpretation errors

Part III: Missed breast cancer: Avoiding this pitfall

November 16, 2000

Conclusion & References

Part IV: Missed breast cancer: Avoiding this pitfall

November 16, 2000

Table of Contents

November 6, 2000

Interstitial pneumonias

Part II: Interstitial lung diseases: imaging evaluation

October 29, 2000

Idiopathic pulmonary fibrosis

Part III: Instertitial lung diseases: imaging evaluation

October 29, 2000

Nonspecific interstitial pneumonitis

Part IV: Interstitial lung diseases: imaging evaluation

October 29, 2000

Acute interstitial pneumonia

Part V: Interstitial lung diseases: imaging evaluation

October 29, 2000

Alveolar macrophage pneumonia (AMP), previously known as desquamative interstitial pneumonia (DIP) and respiratory bronchiolitis-interstitial lung disease (RB-ILD)

Part VI: Interstitial lung diseases

October 29, 2000

Page 60 of 64